Kimberly G Blumenthal, Daniel A Gundersen, Liam R Smith, Brett Nava-Coulter, Andrew King, Elizabeth J Phillips, Alexei Gonzalez-Estrada, Iris M Otani, Allison Ramsey, Aleena Banerji, Timothy Chow, Cosby A Stone, Whitney A Salinas, David A Khan
{"title":"The Drug Allergy History Tool (DAHT): Validation of a Patient-Reported Survey Instrument.","authors":"Kimberly G Blumenthal, Daniel A Gundersen, Liam R Smith, Brett Nava-Coulter, Andrew King, Elizabeth J Phillips, Alexei Gonzalez-Estrada, Iris M Otani, Allison Ramsey, Aleena Banerji, Timothy Chow, Cosby A Stone, Whitney A Salinas, David A Khan","doi":"10.1016/j.jaci.2025.02.027","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>While the reaction history is critical for drug allergy evaluations and is typically self-reported, there is no validated survey instrument to collect drug allergy history from patients.</p><p><strong>Objective: </strong>To validate a survey instrument that collects patient-reported drug allergy history.</p><p><strong>Methods: </strong>The Drug Allergy History Tool (DAHT) was revised after three rounds of cognitive testing, with data assessed for reliability, through test-retest comparison, and quality and validity, through a concordance analysis against electronic health record (EHR) allergist documentation. Participants completing testing and surveys were recruited from drug allergy clinics at Massachusetts General Hospital. Primary evaluative measures were percent agreement and Kappa statistic values.</p><p><strong>Results: </strong>The DAHT was completed by 79 individuals (mean age 49 [SD 17] years, 85% Female, 85% White, 11% Hispanic ethnicity); 29 with single-drug allergy labels and 50 with multiple drug allergy labels. The most common drug allergy labels were penicillins (77%), sulfonamides (32%), cephalosporins (15%), and nonsteroidal anti-inflammatory drugs (8%). DAHT achieved acceptable test-retest reliability (median Kappa = 0.64, median percent agreement = 86%). The DAHT achieved a more complete allergy history than the allergist documentation in the EHR with lower median item uncertainty (21% DAHT vs 79% EHR) with fair concordance (median Kappa = 0.21, median percent agreement = 67%) between the two data sources.</p><p><strong>Conclusion: </strong>The DAHT is a reliable and valid source of patient-reported allergy information. This tool can be used in clinical care and clinical research to obtain standardized patient reported drug allergy history.</p>","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":" ","pages":""},"PeriodicalIF":11.4000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaci.2025.02.027","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: While the reaction history is critical for drug allergy evaluations and is typically self-reported, there is no validated survey instrument to collect drug allergy history from patients.
Objective: To validate a survey instrument that collects patient-reported drug allergy history.
Methods: The Drug Allergy History Tool (DAHT) was revised after three rounds of cognitive testing, with data assessed for reliability, through test-retest comparison, and quality and validity, through a concordance analysis against electronic health record (EHR) allergist documentation. Participants completing testing and surveys were recruited from drug allergy clinics at Massachusetts General Hospital. Primary evaluative measures were percent agreement and Kappa statistic values.
Results: The DAHT was completed by 79 individuals (mean age 49 [SD 17] years, 85% Female, 85% White, 11% Hispanic ethnicity); 29 with single-drug allergy labels and 50 with multiple drug allergy labels. The most common drug allergy labels were penicillins (77%), sulfonamides (32%), cephalosporins (15%), and nonsteroidal anti-inflammatory drugs (8%). DAHT achieved acceptable test-retest reliability (median Kappa = 0.64, median percent agreement = 86%). The DAHT achieved a more complete allergy history than the allergist documentation in the EHR with lower median item uncertainty (21% DAHT vs 79% EHR) with fair concordance (median Kappa = 0.21, median percent agreement = 67%) between the two data sources.
Conclusion: The DAHT is a reliable and valid source of patient-reported allergy information. This tool can be used in clinical care and clinical research to obtain standardized patient reported drug allergy history.
期刊介绍:
The Journal of Allergy and Clinical Immunology is a prestigious publication that features groundbreaking research in the fields of Allergy, Asthma, and Immunology. This influential journal publishes high-impact research papers that explore various topics, including asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases. The articles not only report on clinical trials and mechanistic studies but also provide insights into novel therapies, underlying mechanisms, and important discoveries that contribute to our understanding of these diseases. By sharing this valuable information, the journal aims to enhance the diagnosis and management of patients in the future.